Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Dose-finding Study to Determine if Oral BEZ235 Alone or in Combination With RAD001 Decreases the Incidence of Respiratory Tract Infections in Elderly Subjects

NCT03373903 is registered in ClinicalTrials.gov with Restorbio Inc. as lead sponsor.

NCT NCT03373903
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03373903 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Dose-finding Study to Determine if Oral BEZ235 Alone or in Combination With RAD001 Decreases the Incidence of Respiratory Tract Infections in Elderly Subjects
Lead sponsor
Restorbio Inc.
Phase
Phase 2
Overall status
Active, not recruiting
Start date
November 15, 2017
Completion date
July 31, 2018
Enrollment
652 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

respiratory tract infections